Development of PI3K inhibitors: lessons learned from early clinical trials

Jordi Rodón(Vall d'Hebron Institut de Recerca), Rodrigo Dienstmann(Vall d'Hebron Institut de Recerca), Violeta Serra(Vall d'Hebron Institut de Recerca), Josep Tabernero(Universitat Autònoma de Barcelona)
Nature Reviews Clinical Oncology
February 12, 2013
Cited by 766

Abstract


Related Papers

No related papers found

Powered by citation graph analysis